Viewing Study NCT03983395


Ignite Creation Date: 2025-12-24 @ 1:14 PM
Ignite Modification Date: 2026-01-01 @ 10:05 AM
Study NCT ID: NCT03983395
Status: TERMINATED
Last Update Posted: 2021-05-24
First Post: 2019-05-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer
Sponsor: Ichnos Sciences SA
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module